In glioblastoma-derived cell lines, valproic acid (VPA) causes a dose-dependent downregulation of PON2, which is reversible by 1-benzoyl-3-phenyl-2-thiourea (Tseng et al. 2017). The gene discussed is PON2; the disease is glioblastoma.